{"id":107163,"date":"2021-02-16T12:37:59","date_gmt":"2021-02-16T12:37:59","guid":{"rendered":"https:\/\/fin2me.com\/?p=107163"},"modified":"2021-02-16T12:37:59","modified_gmt":"2021-02-16T12:37:59","slug":"cvs-health-q4-results-top-estimates","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","title":{"rendered":"CVS Health Q4 Results Top Estimates"},"content":{"rendered":"

CVS Health Corp. (CVS) reported on Wednesday a profit for the fourth quarter that declined 44 percent from last year, hurt by higher benefit costs and expenses, despite a 4 percent revenue growth. Both adjusted earnings per share from continuing operations and quarterly revenues topped analysts’ expectations. The company also initiated earnings and adjusted earnings guidance for the full-year 2021.<\/p>\n

For the fourth quarter, the company reported net income attributable to the company of $973 million or $0.74 per share, sharply lower than $1.75 billion or $1.33 per share in the prior-year quarter.<\/p>\n

Excluding items, adjusted income from continuing operations attributable to the company for the quarter was $1.71 billion or $1.30 per share, compared to $2.27 billion or $1.73 per share in the year-ago quarter.<\/p>\n

On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $1.24 per share for the quarter. Analysts’ estimates typically exclude special items.<\/p>\n

Total revenues for the quarter grew 4.0 percent to $69.55 billion from $66.89 billion in the same quarter last year, primarily driven by growth in the Health Care Benefits and Retail\/LTC segments. Analysts expected revenues of $68.75 billion for the quarter.<\/p>\n

The Pharmacy Services segment revenues declined 1.9 percent to $36.36 billion from $37.07 billion, while Retail\/LTC segment revenues grew 6.6 percent to $24.06 billion from $22.58 billion and Health Care Benefits segment revenues increased 11.4 percent to $19.10 billion from $17.15 billion from last year.<\/p>\n

Looking ahead for 2021, the company expects earnings from continuing operations in range of $6.06 to $6.22 per share, and adjusted earnings in a range of $7.39 to $7.55 per share. Analysts expect annual earnings of $7.54 per share. <\/p>\n

CVS Health is in the process of administering COVID-19 vaccinations to eligible people after inking a public-private Pharmacy Partnership with the U.S. government to provide and administer COVID-19 vaccines to protect vulnerable American residents of long-term care facilities (LTCF) nationwide with no out-of-pocket costs. <\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

CVS Health Corp. (CVS) reported on Wednesday a profit for the fourth quarter that declined 44 percent from last year, hurt by higher benefit costs […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"\nCVS Health Q4 Results Top Estimates - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CVS Health Q4 Results Top Estimates - Fin2me\" \/>\n<meta property=\"og:description\" content=\"CVS Health Corp. (CVS) reported on Wednesday a profit for the fourth quarter that declined 44 percent from last year, hurt by higher benefit costs [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-16T12:37:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2018\/07\/TQhauKsZaWagomfidiOJ.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2449\" \/>\n\t<meta property=\"og:image:height\" content=\"1633\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/\",\"url\":\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/\",\"name\":\"CVS Health Q4 Results Top Estimates - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-02-16T12:37:59+00:00\",\"dateModified\":\"2021-02-16T12:37:59+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CVS Health Q4 Results Top Estimates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CVS Health Q4 Results Top Estimates - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","og_locale":"en_US","og_type":"article","og_title":"CVS Health Q4 Results Top Estimates - Fin2me","og_description":"CVS Health Corp. (CVS) reported on Wednesday a profit for the fourth quarter that declined 44 percent from last year, hurt by higher benefit costs [...]","og_url":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","og_site_name":"Fin2me","article_published_time":"2021-02-16T12:37:59+00:00","og_image":[{"width":2449,"height":1633,"url":"https:\/\/fin2me.com\/wp-content\/uploads\/2018\/07\/TQhauKsZaWagomfidiOJ.jpg","type":"image\/jpeg"}],"author":"Mark","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","url":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/","name":"CVS Health Q4 Results Top Estimates - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-02-16T12:37:59+00:00","dateModified":"2021-02-16T12:37:59+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/cvs-health-q4-results-top-estimates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"CVS Health Q4 Results Top Estimates"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107163"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=107163"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107163\/revisions"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=107163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=107163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=107163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}